D-238-2013 Class III Terminated

Recalled by Dr. Reddy'S Laboratories — Bridgewater, NJ

FDA drug recall D-238-2013 was initiated by Dr. Reddy'S Laboratories on Mar 19, 2013 and is designated Class III. Reason for recall: Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details. The recall status is terminated (terminated Feb 6, 2014). Affected quantity: 117,546 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 10, 2013
Initiation Date
Mar 19, 2013
Termination Date
Feb 6, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
117,546 bottles

Product description

Tizanidine Tablets USP, 4 mg, 150-count tablets per bottle, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepally - 500 090 India; NDC 55111-180-15.

Reason for recall

Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.

Distribution pattern

Nationwide and Puerto Rico.

Code information

Lot #: C208625, C208984, C209113, C209369, Exp 09/15; and C209680, Exp 10/15.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-238-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-238-2013. Report a data issue: hello@regdatalab.com.